Profit before interest, taxes and amortization: Axsome Therapeutics, Inc. (AXSM)
Axsome Therapeutics (AXSM) maintains a high standing in neurotherapy, providing treatments for depression and migraines funded by insurance payouts. Operating cash flow before depreciation on GURU.Markets demonstrates the current trend, where the 0.00 mark reflects the latest data. Revenue growth is supported by active sales of new proprietary drugs, creating strong momentum for business development.
Axsome Therapeutics, Inc. - analytical breakdowns and key metrics (AXSM)
- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
- book capitalization data:
- debt level and financial liquidity data:
All Debt to Shareholders' Equity Ratio Axsome Therapeutics|AXSM - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio Axsome|AXSM - Company Aggregate Debts|Debt to Net Assets Ratio Axsome Therapeutics|AXSM - Company Long-Term Debts|Short-Term Debt Axsome Therapeutics|Intermediate Coverage Ratio axsome.com
- earnings and multiples data:
AXSM - Net Profit|Projected Future Earnings Axsome Therapeutics|AXSM - Price to Earnings Ratio|Price to Expected Earnings Ratio axsome.com|AXSM - PEG Multiple|Company Value to EBITDA Axsome Therapeutics|AXSM - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Axsome Therapeutics|AXSM - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months axsome.com|AXSM - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Axsome Therapeutics
Summary company analytics:Axsome Corp
The commercial expansion of Auvelity and Sunosi directly determines the cash flow volume that the EBITDA_Co metric captures through operating profit before depreciation and interest. This metric allows investors to assess the actual ability of Axsome Therapeutics (AXSM) to generate cash for pipeline development, excluding the impact of debt load and accounting write-offs when analyzing the fundamental stability of the business.
Who Axsome Therapeutics competes with
Operating income before deduction of amortization Biogen Idec (BIIB)|NBIX - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization regencellbioscience.com|ACADIA Pharmaceuticals Inc. (ACAD) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Xenon Pharmaceuticals Inc.|VKTX (Viking Pharma) - Operating profit EBITDA|Profit before interest, taxes and amortization Supernus Corp SUPN|Operating profit before deduction of amortization CPRX (Catalyst Pharmaceuticals)|DNLI (denalitherapeutics.com) - Income before deduction of interest, taxes and amortization|Harmony Biosciences Holdings, Inc. - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization BHVN (Biohaven Ltd)|Amylyx - Operating profit EBITDA|Income before deduction of interest, taxes and amortization TRVI (Trevi Corp)|PRAX: Operating profit EBITDA|Profit before interest, taxes and amortization anavex.com (AVXL)|Profit before payment of interest, taxes and amortization CeriBell|PRTA: Income before deduction of interest, taxes and amortization|Operating profit EBITDA ALEC|Operating profit EBITDA Annexon Biosciences Inc. (ANNX)|Profit before payment of interest, taxes and amortization Omeros OMER|NGNE (neurogene.com) - Profit before deduction of interest, taxes, depreciation and amortization|AC Immune SA - Operating profit EBITDA|Profit before interest, taxes and amortization Voyager Therapeutics Inc|NMRA (Neumora Therapeutics Inc) - Operating profit before deduction of amortization|Scilex Holding Company, Inc. (SCLX) - Operating profit EBITDA|Operating profit before deduction of amortization TVGN|ACOG (Alpha Cognition Corp) - Company profit before taxes, interest and amortization|Operating profit EBITDA CGTX|Operating income before deduction of amortization Inhibikase Therapeutics Inc|Operating profit EBITDA SAVA (Cassava)|ASRT - Operating profit before deduction of amortization|COYA - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization Vistagen Therapeutics VTGN|OVID: Operating profit EBITDA|Acumen Pharmaceuticals Inc. (ABOS) - Operating profit EBITDA|Operating profit before deduction of amortization CRVO|Operating profit before amortization ATHE (Alterity Therapeutics Ltd)|Profit before payment of interest, taxes and amortization Clene Inc. (CLNN)|Operating income before deduction of amortization pepgen.com|Profit before payment of interest, taxes and amortization Jupiter Neurosciences JUNS|RLMD - Operating profit before deduction of amortization|ANVS - Profit before payment of interest, taxes and amortization|GRCE (Grace Therapeutics, Inc.) - Operating profit before amortization|AIFF: Operating profit EBITDA|Profit before interest, taxes and amortization Klotho Neurosciences (KLTO)|Operating profit before deduction of amortization NRSN|Operating profit EBITDA Reviva Pharmaceuticals Holdings Inc.|Profit before payment of interest, taxes and amortization MetaVia Inc (MTVA)|NRXS (NeurAxis Inc) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Helius Medical Technologies HSDT|Passage Bio Inc. (PASG) - Profit before interest, taxes and amortization|Neuphoria - Operating profit EBITDA|NERV - Operating profit EBITDA|ATHA (Athira) - Operating profit before deduction of amortization|Operating profit before amortization ADXN|Profit before payment of interest, taxes and amortization Alzamend Neuro Inc.|Cyclerion (CYCN) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Protagenic Therapeutics (PTIX)|KTTA - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Cortigent CRGT|ATXI - Operating profit before deduction of amortization|Brainstorm Cell - Operating profit EBITDA|Profit before interest, taxes and amortization caratherapeutics.com|CHRO (Chromocell Therapeutics Corp.) - Operating profit before deduction of amortization|Eliem Therapeutics Inc. - Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization ITCI|LBPH (Longboard) - Company profit before taxes, interest and amortization|Operating profit EBITDA MRNS|NKGN (nkgenbiotech.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA NRBO (NeuroBo Pharmaceuticals, Inc.)|Sage Therapeutics Inc. (SAGE) - Profit before interest, taxes and amortization|SNPX - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization TRVN (Trevena Inc)|VIGL: Operating profit EBITDA|anewmeds.com (WENA) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Cerevel Therapeutics, Inc.
